568PA phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI